key: cord-0790531-icos7txw authors: Master, R. K.; Aron, L. Y.; Woolf, S. title: CHANGES IN LIFE EXPECTANCY BETWEEN 2019 AND 2021: UNITED STATES AND 19 PEER COUNTRIES date: 2022-04-07 journal: nan DOI: 10.1101/2022.04.05.22273393 sha: df01700c2853516927aa8944be2d607d3905c9c9 doc_id: 790531 cord_uid: icos7txw BACKGROUND Prior studies reported large decreases in US life expectancy during 2020 as a result of the COVID-19 pandemic, disproportionately affecting Hispanic and Black populations and vastly exceeding the average change in life expectancy in other high-income countries. Life expectancy estimates for 2021 have not been reported. This study estimated changes in life expectancy during 2019-2021 in the US population, in three US racial/ethnic groups, and in 19 peer countries. METHODS US and peer country death data for 2019-2021 were obtained from the National Center for Health Statistics, the Human Mortality Database, and overseas statistical agencies. The 19 peer countries included Austria, Belgium, Denmark, England and Wales, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Scotland, South Korea, Spain, Sweden, and Switzerland. Life expectancy was calculated for 2019 and 2020 and estimated for 2021 using a previously validated modeling method. RESULTS US life expectancy decreased from 78.86 years in 2019 to 76.99 years in 2020 and 76.60 years in 2021, a net loss of 2.26 years. In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.40 years) and a 0.28-year increase between 2020 and 2021, widening the gap in life expectancy between the United States and peer countries to more than five years. The decrease in US life expectancy was highly racialized: whereas the largest decreases in 2020 occurred among Hispanic and non-Hispanic Black populations, in 2021 only the non-Hispanic White population experienced a decrease in life expectancy. DISCUSSION The US mortality experience during 2020 and 2021 was more severe than in peer countries, deepening a US disadvantage in health and survival that has been building for decades. Over the two-year period between 2019 and 2021, US Hispanic and non-Hispanic Black populations experienced the largest losses in life expectancy, reflecting the legacy of systemic racism and inadequacies in the US handling of the pandemic. Reasons for the crossover in racialized outcomes between 2020 and 2021, in which life expectancy decreased only in the non-Hispanic White population, could have multiple explanations. US life expectancy decreased from 78.86 years in 2019 to 76.99 years in 2020 and 76.60 years in 2021, a net loss of 2.26 years. In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.57 years) and a 0.28-year increase between 2020 and 2021, widening the gap in life expectancy between the United States and peer countries to more than five years. The decrease in US life expectancy was highly racialized: whereas the largest decreases in 2020 occurred among Hispanic and non-Hispanic Black populations, in 2021 only the non-Hispanic White population experienced a decrease in life expectancy. The US mortality experience during 2020 and 2021 was more severe than in peer countries, deepening a US disadvantage in health and survival that has been building for decades. Over the two-year period between 2019 and 2021, US Hispanic and non-Hispanic Black populations experienced the largest losses in life expectancy, reflecting the legacy of systemic racism and inadequacies in the US handling of the pandemic. Reasons for the crossover in racialized outcomes between 2020 and 2021, in which life expectancy decreased only in the non-Hispanic White population, could have multiple explanations. In 2020, the United States (US) experienced a much larger decline in life expectancy than did other highincome countries, with disproportionately large losses in its Hispanic and Black populations. 1 Although the introduction and availability of effective vaccines were expected to curb US mortality rates in 2021, slow vaccine uptake and the spread of the Delta variant produced large surges in mortality. This study used official mortality data for 2018-2020 and provisional mortality data for 2021 to estimate changes in life expectancy in the US population, in three US racial/ethnic groups, and in 19 peer countries. Methods used previously to estimate life expectancy for 2020 based on provisional death counts 1 were replicated for 2021. Official and provisional mortality data for US populations were obtained from the National Center for Health Statistics. 2, 3 Data for 19 other high-income peer countries were obtained from the Human Mortality Database (HMD), direct sources, and the HMD Shortterm Mortality Fluctuation series. 4 Data for all countries were stratified by sex, and US data were further stratified by race and ethnicity for Hispanic and non-Hispanic Black and White populations (see supplementary material for details). A credible range (CR) for life expectancy in 2021 was calculated by simulating life tables from estimated age-specific mortality rates and allowing for 10% random error. Life expectancy change, years . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 7, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 Limitations of this analysis include the reliance on provisional data for 2021 and extrapolation of population counts based on data from 2017-2020, cross-country variation in reporting of deaths, and the exclusion of some high-income countries (e.g., Australia, Japan) and US racial groups (e.g., American Indian/Alaska Native) due to insufficient data. Peer Average New Zealand 81 Note: CR = credible range Red shading indicates a decrease in life expectancy and green shading indicates an increase; significant decreases and increases in 2021 are determined by the CR Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data National Center for Health Statistics. AH Excess Deaths by Sex, Age, and Race. HealthData.gov US Health in International Perspective: Shorter Lives, Poorer Health Racism and Health: Evidence and Needed Research Making sense of the US COVID-19 pandemic response: A policy regime perspective COVID-19 and the US response: accelerating health inequities The authors report no conflicts of interest. Dr. Masters received support from the University of Colorado Population Center grant from the Eunice Kennedy Shriver Institute of Child Health and Human Development (CUPC project 2P2CHD066613-06). Dr. Woolf received partial funding from grant UL1TR002649 from the National Center for Advancing Translational Sciences. There was no specific funding for this study. The above funders had no role in the design and conduct of the study.